Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 2Neoplasm Metastasis 2Sarcoma, Synovial 1Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neuroendocrine Tumors 1Mouth Neoplasms 1Lymphatic Metastasis 1Liposarcoma 1Leukemia, Myeloid, Acute 1Leiomyosarcoma 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Histiocytoma, Malignant Fibrous 1Gliosarcoma 1Glioblastoma 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Dermatofibrosarcoma 1Cholangiocarcinoma 1Carcinoma 1

Interventions

Magnetic Resonance Spectroscopy 15Specimen Handling 13Cisplatin 13pembrolizumab 10Radiotherapy, Intensity-Modulated 9Carboplatin 9Platinum 81,2-diaminocyclohexaneplatinum II citrate 8Cetuximab 7Radiotherapy 5Radiation 5Paclitaxel 5Biopsy 5Taxes 4(225)Ac-DOTA-c(RGDyK) 4cemiplimab 3Docetaxel 3ipatasertib 2durvalumab 2X-Rays 2Surgical Procedures, Operative 2Standard of Care 2Interviews as Topic 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Drug Therapy 2Disulfides 2Chemoradiotherapy 2trametinib 1toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Laryngeal Neoplasms × peposertib × 1 year × Clear all
NCT04533750 2026-04-13

Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin

National Cancer Institute (NCI)

Phase 1 Active not recruiting
21 enrolled
Head & Neck

Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡